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Abstract
Introduction: The aim of this study was the comparison of 24h urine free cortisol (UFC), serum cortisol at 11pm (SCM) and late-night 
salivary cortisol (LSC) in patients suspected for hypercortisolism, and an assessment of the usefulness of these measurements in diagnos-
ing overt Cushing’s (OCS) syndrome, pseudo Cushing’s state (PCS) and subclinical Cushing’s syndrome (SCS).
Material and methods: The study group consisted of 82 patients, of whom four patients had SCS, three OCS and eight PCS. For measure-
ments of LSC, the ELISA method was used, and for UFC and SCM determination, chemiluminescent microparticle immunoassay was used. 
Results: The highest correlation coefficient characterised LSC and SCM (r = 0.72). Area under curve (AUC) for SCM and LSC in receiver 
operating characteristic (ROC) for OCS was: 0.86 v. 0.74; for PCS: 0.83 v. 0.70; and for SCS: 0.74 v. 0.79.
Conclusions: Our findings suggest that LSC is more useful compared to SCM in diagnosing subclinical Cushing’s syndrome. Moreover, 
LSC seems to be a valuable diagnostic criterion to distinguish pseudo Cushing’s state. However, to obtain reliable cut-offs for LSC values, 
a larger group of hypercortisolic patients is needed. (Endokrynol Pol 2013; 64 (4): 263–267)
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Streszczenie
Wstęp: Celem pracy było porównanie oznaczeń kortyzolu w surowicy o 23 godz. (SCM), późnowieczornego stężenia kortyzolu w śli-
nie (LSC), wolnego kortyzolu z dobowej zbiórki moczu (UFC) u pacjentów z podejrzeniem endogennej hiperkortyzolemii oraz ocena 
przydatności tych oznaczeń w diagnostyce jawnego zespołu Cushinga (OCS), rzekomego zespołu Cushinga (PCS) oraz subklinicznego 
zespołu Cushinga (SCS).
Materiał i metody: Badania przeprowadzono u 82 pacjentów, wśród których u 4 zdiagnozowano SCS, u 3 OCS oraz u 8 PCS. Do ozna-
czenia LSC użyto metody immunoenzymatycznej, UFC oraz SCM oznaczono metodą immunochemiluminescencji. Wyniki: Najwyższy 
współczynnik korelacji charakteryzował LSC oraz SCM (r = 0,72). Pole pod krzywą (AUC) dla SCM i LSC w analizie charakterystyki 
operacyjnej odbiornika (ROC) dla OSC wynosiło odpowiednio 0,86 v. 0,74 dla PCS: 0,83 v. 0,70 dla SCS: 0,74 v. 0,79.
Wnioski: Uzyskane wyniki wskazują, że LSC jest bardziej przydatny w porównaniu do SCM w diagnostyce subklinicznego zespołu 
Cushinga. LSC również wydaje się być wartościowym kryterium diagnostycznym w różnicowaniu rzekomego zespołu Cushinga. 
Jednakże do określenia wiarygodnych punktów odcięcia dla LSC potrzebne są badania przeprowadzone w większej grupie chorych 
z hyperkortyzolizmem. (Endokrynol Pol 2013; 64 (4): 263–267)
Słowa kluczowe: kortyzol w ślinie, kortyzol w surowicy, wolny kortyzol w moczu, jawny zespół Cushinga, subkliniczny zespół Cushinga, 
rzekomy zespół Cushinga
Introduction
The most frequent indications to perform diagnostics 
of hypercortisolism are typical signs and symptoms 
for Cushing’s syndrome (CS) and/or adrenal inci-
dentaloma (AI). Although the most common type 
of hypercortisolism is ACTH-dependent Cushing’s 
syndrome, there is increasing incidence of adrenal 
incidentaloma due to the widespread use of ad-
vanced imaging techniques like ultrasonography or 
computed tomography. The incidence of AI increases 
with a patient’s age and reaches over 7% in the gen-
eral population aged over 70 years [1]. The 5-20% of 
AI cases that have been reported to show mild cortisol 
excess without any specific signs and symptoms of 
CS are termed subclinical Cushing’s syndrome (SCS) 
[2–6]. Overt CS usually develops demonstrative 
signs like reddish-purple striae, plethora, proximal 
muscle weakness, bruising with no obvious trauma, 
and unexplained osteoporosis [7]. In such patients, 
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confirmation of CS by biochemical tests is usually 
easy, while diagnosis of SCS remains controversial. 
Another problem of clinical importance is to distin-
guish CS with pseudo Cushing’s states (PCS) related 
to overactivity of the hypothalamic-pituitary-adrenal 
axis in patients complaining of depression, visceral 
obesity, polycystic ovaries syndrome, poorly controlled 
diabetes, anorexia, menstrual irregularity and chronic 
alcoholism [8]. On the one hand, depression, diabetes, 
obesity, hypertension, osteoporosis or menstrual ir-
regularity may constitute symptoms of cortisol excess. 
On the other hand, these conditions are common in the 
general population [9, 10]. 
A challenge for the endocrinologist is to differentiate 
between SCS and PCS in a patient with AI. Dexameth-
asone-suppressed corticotropin-releasing hormone 
stimulation test and the desmopressin test performed in 
endocrinology departments do not guarantee absolute 
diagnostic accuracy, while the number of such patients 
continues to increase [11]. 
Thus, reliable, easy to perform and cheap meth-
ods are needed for hypercortisolism diagnostics that 
would be convenient in outpatients. Current clinical 
guidelines recommend the initial use of one of the 
following tests: 24-h urinary free cortisol (UFC), 
late-night salivary cortisol (LSC) and serum cortisol 
after 1 mg overnight dexamethasone suppression 
test (DST) [12]. Late-night salivary cortisol seems the 
best choice as an initial test, compared to DST, UFC 
and serum cortisol measurement (SCM) because of 
its highest sensitivity [13]. Moreover, LSC is a non-
invasive procedure, free of stress and easy to collect 
and store. In addition, saliva contains stable cortisol 
and is unaffected by alterations in cortisol-binding 
globulin [14]. 
Thus, the aim of this study was a comparison of 
UFC, SCM and LSC in patients suspected for hyper-
cortisolism and an assessment of their usefulness in 
diagnosing CS, PCS and SCS.
Material and methods
The study group consisted of 82 patients admitted to 
the Department of Endocrinology, Diabetology and 
Internal Diseases of the Medical University in Bialystok 
between 2009 and 2011 who were diagnosed because 
of a suspicion of hypercortisolism. The most frequent 
indication for screening of Cushing’s syndrome was 
the presence of signs and symptoms suggestive of 
hypercortisolism: 43 of the 82 (52%). In 33 cases (40%), 
patients were diagnosed with AI, and six (7%) had 
pituitary adenoma. 
Saliva and serum were collected at 8am and 
11pm. 24-hour urine collection was used for UFC 
determination. DST was performed typically by 
measurement of serum cortisol in morning sample 
(8am) after administration of 1 mg dexamethasone 
at 11pm the previous night. Salivary cortisol was 
measured using a Lucio — Medical ELISA Salivary 
Cortisol HS kit (analytic sensitivity < 0.012 ng/mL, 
specificity for cortisol 100%, intra- and interassay 
CV was respectively < 4.94% and < 4.07%). Che-
miluminescent microparticle immunoassay (CMIA) 
by ARCHITECT of Abbott Laboratories was used to 
determine cortisol in serum and in urine (functional 
sensitivity assay of < 1μg/dL, specificity for cortisol 
was 100% assay precision of < 10% total CV for serum 
samples > 3 to < 35 μg/dL and < 20% total CV for 
urine samples > 3 to < 35 μg/dL.) 
In patients with AI, a 16-slice CT was performed with 
description of tissue density using Hounsfield’s scale.
Three types of hypercortisolism were distinguished. 
Subclinical Cushing’s syndrome was diagnosed in four 
cases who had cortisol in serum above 1.8 μg/dL in 
DST (the indication for screening in all SCS patients 
was AI), three patients with overt CS (two with pitu-
itary adenoma and one with ectopic ACTH-producing 
tumour) and eight patients with PCS. The PCS group 
consisted of four patients with depression (including 
one with poorly controlled diabetes), three obese (BMI 
> 30), and one with anorexia. 
To evaluate relationships between LSC, SCM and 
UFC, Spearman’s test was performed using Statistica 
10.0 (StatSoft, Tulsa, OK, USA). In each type of hypercor-
tisolism, receiver operating characteristic (ROC) analy-
sis for LSC and SCM was performed using STATA 11. 
Results
We observed positive correlations in all variables. The 
highest R value (R = 0.72) characterised the correla-
tion between LSC and SCM (Fig. 1). Relatively low R 
values characterised UFC in correlation with LSC and 
SCM (R = 0.37 and R = 0.47 respectively), thus ROC 
analysis for this variable was not performed. In ROC 
analysis for LSC and SCM, graphs indicate slightly 
higher area under the curve (AUC) for LSC (AUC = 0.79) 
compared to SCM (AUC = 0.74) for patients with SCS 
(Fig. 2). Cut-off point for LSC in this case was 0.82 μg/dL 
with sensitivity 75% and specificity 89%. On the other 
hand, in patients with overt Cushing’s syndrome (Fig. 3), 
AUC was significantly higher for cortisol in serum (AUC 
= 0.86) than in saliva (AUC = 0.74). Sensitivity and speci-
ficity reached 80% for 6.2 μg/dL. For LSC measurement, 
sensitivity reached 100% at specificity 49% with 0.16 μg/dL. 
In patients with PCS (Fig. 4), serum cortisol more often 
indicated patients with hypercortisolemia: ROC area: 
0.83 v. 0.70. 
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Discussion
Results of the present study have shown a satisfac-
tory correlation between LSC and SCM, which does 
not agree with previous publications [15-17]. For this 
reason, this method is carefully investigated in patients 
suspected for hypercortisolism. Recently published 
studies have shown that LSC is a convenient screen-
ing test for overt Cushing’s syndrome [10,18,19]. The 
cut-off values for LSC in OCS reported in these studies 
varied from 0.13 to 0.55 μg/dL, with high sensitivities 
and specificities. More problematic is establishing the 
cut-off value in diagnosis of SCS. In our study, LSC 
measurement in SCS cases reached sensitivity of 75% 
and specificity of 89% for 0.82 μg/dL. A low sensitivity 
(22.7%), but high specificity (87.7%) for cut-off 0.18 μg/
dL characterised LSC in the study by Masserini et al. 
[20]. In the analysis of Nunes et al., sensitivity and speci-
ficity were comparable (77% and 69% respectively) for 
0.17 μg/dL [21]. By contrast, Yuko Tateishi et al. indicated 
0.11 μg/dL value of LSC with 100% sensitivity but only 
50% specificity [22]. 
Figure 2. ROC and AUC analysis for subclinical Cushing’s 
syndrome
Rycina 2. Krzywe ROC oraz AUC dla subklinicznego zespołu 
Cushinga
Figure 3. ROC curves and AUC analysis for overt Cushing’s 
syndrome
Rycina 3. Krzywe ROC oraz AUC dla jawnego zespołu Cushinga
Figure 4. ROC and AUC analysis for pseudo Cushing’s state
Rycina 4. Krzywe ROC oraz AUC dla rzekomego zespołu 
Cushinga
Figure 1. Spearman’s rank correlation of late-night salivary 
cortisol and serum (R = 0.72) 
Rycina 1. Korelacja rang Spearman’a dla późnowieczornego 
kortyzolu we ślinie i w surowicy (R = 0,72)
Differences between presented results may be 
explained by different diagnostic criteria for SCS 
and different assay methods used. Salivary corti-
sol has been usually measured by RIA and ELISA 
[18,19,23,25,26] and much more rarely by electro-
chemiluminescent immunoassay (ECLIA) or liquid 
chromatography tandem mass spectrometry (LC-MS/ 
/MS) [23, 27, 28]. The study by Beko et al. revealed bet-
ter performance of LSC using ECLIA (sensitivity 100% 
and specificity 88%) compared to RIA (sensitivity 
100% and specificity 71%) [23]. Another study demon-
strated an important rate of abnormal LSC results in 
volunteers without evidence of Cushing’s syndrome 
when measured using two different commercial 
assays and evaluated with laboratory provided nor-
mative ranges [24]. Assays of RIA and ELISA can be 
affected by cross-reactivity with cortisol metabolites 
and synthetic glucocorticoids. Liquid chromatogra-
phy tandem mass spectrometry does not pose this 
problem, but some drugs such as carbamazepine or 
fenofibrate may interfere in this method and cause 
falsely elevated values [29]. In addition, patients with 
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SCS and adrenal incidentaloma are characterised by 
a fluctuated cortisol secretion and may not reveal 
abnormal cortisol in a single measurement [30]. 
Our study suggests that LSC is better than SCM 
as a diagnostic criterion of PCS, as far as it enables 
reduction of false positive results of Cushing’s syn-
drome. Thus, LSC seems a reliable method especially 
in patients with elevated cortisol binding globulin in 
serum (e.g. obese or those taking carbamazepine or 
oral contraceptives).
Another aspect of salivary cortisol procedure is 
sample collection and storage. Saliva collection should 
be done between 11 pm and midnight. In healthy indi-
viduals with stable circadian rhythm, the level of serum 
cortisol begins to rise at 3 am–4 am, reaching its peak 
at 7 am-9 am and then falling by the end of the day to 
its lowest value. Loss of circadian rhythm is typical for 
Cushing’s syndrome but also can occur due to the stress 
of hospitalisation. Most clinicians ask patients to collect 
saliva samples on two separate evenings at home. Saliva 
is collected by drooling into a plastic tube or by placing 
a cotton pledget in the mouth and chewing for 1–2 min. 
The sample is stable at room temperature for several 
weeks. In healthy volunteers, salivary cortisol concen-
trations are highly correlated with those in plasma, 
urine and cerebrospinal fluid and have been assumed 
to represent only free cortisol [31–35]. Several factors 
may substantially influence salivary cortisol measure-
ments. The salivary glands express 11b-hydroxysteroid 
dehydrogenase type 2, so patients chewing tobacco or 
using products containing liquorice may have falsely 
elevated LSC. Patients who smoke cigarettes have been 
shown to have higher LSC than non-smokers [36]. On 
the other hand, avoiding smoking can cause changes 
in cortisol levels for smokers, possibly due to the stress 
of non-smoking [32]. When first including salivary cor-
tisol as a study aim, scientists used various substances 
to stimulate saliva such as citric acid, gum or instant 
fruit drinks. Results showed that some substances, 
especially acidic substances, can give erroneously high 
readings [37, 38]. 
Conclusion
Our findings suggest that LSC is more useful than SCM 
in diagnosing SCS. LSC also seems to be a valuable 
diagnostic criterion to distinguish pseudo Cushing’s 
state. However, to obtain reliable cut-offs for LSC, 
a larger group of hypercortisolic cases is needed.
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